Blue Eagle Lithium
High Times
Home > Boards > US OTC > Biotechs >

PuraMed BioScience, Inc. (PMBS)

PMBS RSS Feed
Add PMBS Price Alert      Hide Sticky   Hide Intro
Moderator: wodehouse, rs99, mikewazowski, skizimus
Search This Board: 
Last Post: 10/22/2018 9:32:31 PM - Followers: 291 - Board type: Free - Posts Today: 0



PuraMed BioScience Develops a Cannabis-based Epilepsy Medication

http://finance.yahoo.com/news/puramed-bioscience-develops-cannabis-based-180000630.html


OTCPINK
PuraMed BioScience, Inc. is a U.S. SEC Registered & Reporting Company
http://www.otcmarkets.com/stock/pmbs/quote
PMBS

http://www.lipigesic.com/



Share Structure:
 As Of January 9th, 2015  O/S ? And Growing.

As Of January 9th 2015  4 Billion Shares Authorized (A/S)

40/1 Reverse Split in the Process which per company filings will result in Approximately 37 Million Shares Outstanding and Meet the OTCQB requi

About the Company

PuraMed was established to capture two unique opportunities. The first is to build a substantial and profitable business, rapidly, beginning with three products developed by its founders: LipiGesic® M (for acute relief of migraine headaches), LipiGesic® H(for acute relief of tension headaches) and PuraMed™ PM (for insomnia). Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class.

The second, longer term, opportunity is to establish a leadership position in the highly fragmented OTC natural and alternative health remedy market by introducing a “new kind of product line.” Our product line will consist of ‘alternative’ remedies for common ailments, marketed to the masses. Most consumers want products that are, first of all, effective and safe. By applying hard science to ‘natural’ products, management believes it is possible to build a line wherein each product delivers better performance with fewer side effects than its chemical counterparts. With effective marketing, these products will be embraced by the majority, many of whom prefer ‘natural’ alternatives, provided there is no need to sacrifice performance or convenience.

PuraMed BioScience has completed a double blind placebo clinical trial for its leading product, LipiGesic® M, a sublingual acute treatment for the relief from migraine headaches, which was published in the top-tier medical journal, Headache. http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2011.01910.x/abstract 
LipiGesic® M has national distribution and is available nationwide in some of the largest chain drug stores in the United States.


CLICK HERE to Read Lipigesic Clinical Trial 2011 Study

CLICK HERE to Read Lipigesic M  Double Blind 2013 Study
 

Products

Feverfew 3X, the main active ingredient in LipiGesic® M (for migraine relief), is an herb that has been recognized for centuries as having a beneficial effect on migraine, menstrual and other headaches. Another active ingredient, Ginger 2X, is anti-inflammatory, specifically suppressing the expression of several mediators felt crucial in migraine pathogenesis.
Read more: http://www.puramedbioscience.com/lipigesic-m/
 

A combination of acetylsalicylic acid (aspirin) and St. John’s Wort delivered utilizing our sublingual gel delivery system can dramatically increase the speed and levels of relief for many tension headache sufferers.
Read more: http://www.puramedbioscience.com/lipigesic-h/
 

Valerian, St. John’s Wort and Chamomile, all ingredients in LipiGesic® PM (for insomnia), have each been clinically demonstrated to promote healthy sleep. 
Read more: http://www.puramedbioscience.com/lipigesic-pm/

 




Where to Buy

New Distributors to be Announced soon!!!

 

 
 

Click Here to Buy Online:

 
http://www.amazon.com/PuraMed-BioScience-LipiGesic-Unit-Dispensers/dp/B00B4201PW
 
 


Recent News

   

PuraMed BioScience Develops a Cannabis-based Epilepsy Medication

 

SCHOFIELD, Wis., Aug. 5, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCPink: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that it plans to begin testing of a new hemp-based epilepsy medication in the fourth quarter of 2014.

"As we looked at the similarities between migraine and epilepsy the treatment path became obvious," saidRussell Mitchell, CEO and Chairman of PuraMed BioScience. "Epilepsy and migraine seem to be triggered by the same coritcal spreading depression (CSD) in the brain; the difference is the rate of reaction. This may be why many migraineurs are prescribed epileptic medications."

According to an article in Seizure, the prevalence of migraine in people who experience epilepsy is 8.4 to 20 percent. In addition to migraine, an estimated 64 percent of epilepsy sufferers also experience seizure-related (ictal) headaches: 20 percent experience headache prior to the seizure (pre-ictal) and 44 percent experience headache after the seizure (post-ictal).

The third most common neurological disorder in the US, epilepsy affects approximately 2.7 million people, with children and older adults being most susceptible. The condition also causes up to 50,000 sudden deaths each year.

Epilepsy affects veterans wounded in combat. According to Citizens United to Cure Epilepsy, approximately 22 percent of the 440,000 military service men and women who experienced traumatic brain injury are expected to develop post-traumatic epilepsy.

"An epilepsy medication is a natural extension to our product line," said Mitchell. "We have developed a formula, now we will begin the setting up the trials. We have been approached by key researchers who have expressed interest in working with us on CBD-based products.

"Standardization is key to creating a quality sublingual formula," said Mitchell. " Sublingual delivery offers the distinct advantages of faster delivery and efficiency while avoiding the "first pass effect" that often degrades oral medications. Our goal is to build medicines that withstand scientific scrutiny and perform well in double-blind, placebo controlled clinical trials. We believe that the efficacy of our formulations will be proven by scientific trials. This type of testing lends credibility to our line of natural medications which often work faster, more effectively, and have fewer side effects than their chemical-based counterparts."

Currently, PuraMed BioScience is rebranding its flagship product, LipiGesic M, as MigraPure.

About MigraPure

MigraPure uses the same sublingual feverfew and ginger formula that was clinically tested as LipiGesic M. The flavor of this homeopathic, all-natural, over-the-counter migraine headache pain relief medication has been enhanced, but the active ingredients that stop disabling migraine pain and associated symptoms quickly, is the same. MigraPure's feverfew and ginger gel is non-drowsy and non-habit forming. MigraPure is not associated with rebound headaches. MigraPure has an excellent safety profile and has no reported drug interactions. 

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to rebranding LipiGesic M to MigraPure, PuraMed BioScience plans to launch additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic products as it moves forward in the development of its cannabinoid product line.

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact: 
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO 
715-359-6373
rmitchell@PuramedBioScience.com 
www.PuramedBioScience.com

PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M

 

SCHOFIELD, Wis., July 30, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCPink:PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that the company is rebranding the LipiGesic® M name along with the name's red and yellow logo. The former will be replaced with the trademarked name MigraPure®  going forward. The new name, logo, and color palette of PuraMed's homeopathic, natural migraine pain reliever will be reintroduced into selected segments of the retail marketplace.

"We've been working on this for over a year," saidRussell Mitchell, CEO and Chairman of PuraMed BioScience. "We needed to secure the trademark for the name and create the image before we announced the development of the enhanced formula and our product line extensions. 

"The new name will be easier for people to remember and pronounce," said Mitchell. "We also believe the new look and color of the logo will convey our 'safe' and 'natural' message at a glance. Preliminary feedback about the change has been positive and we are pleased. We will now have packaging that reflects the excellent product inside."

PuraMed hopes to have the new product, which uses a flavor-enhanced version of the sublingual LipiGesic M formula, new packaging, new price point, and a new website ready for public purchase within the next two months, though promotion and distribution to retailers and targeted wholesale partners will begin earlier.

"The manufacturing order has been placed," said Mitchell. "Our marketing plan is being finalized and as soon as the packaging and the website are ready, we will launch."

MigraPure's fresh look and message will replace the red and yellow LipiGesic logo. A tagline that describes the product will also be a fundamental part of the logo.

"By using a tagline with the image, we can make a stronger statement and leave no doubt in the consumer's mind about what MigraPure is or what it does, which is also an improvement," said Mitchell. "During the re-launch, we will also reference LipiGesic M on the packaging and other marketing materials in order to maintain a connection with our clinical trial data and our current customer base."

Development of the gel, packaging, and launch of the website are the first steps in the rebranding effort. PuraMed plans to continue to sell LipiGesic M under the old label until the new product is available.

A version of the new logo can be seen at www.lipigesic.com/MigraPure.

About MigraPure

MigraPure uses the same sublingual feverfew and ginger formula that was clinically tested as LipiGesic M. The flavor of this all-natural, over-the-counter migraine headache pain relief medication has been enhanced, but the active ingredients that stop disabling migraine pain and associated symptoms quickly, are the same. MigraPure's feverfew and ginger gel is non-drowsy and non-habit forming. MigraPure is not associated with rebound headaches. MigraPure has an excellent safety profile and has no reported drug interactions. 

About PuraMed BioScience, Inc.

PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to rebranding LipiGesic M to MigraPure, PuraMed BioScience plans to launch additional cannabinoid-enhanced, anti-inflammatory, and anxiolytic products as it moves forward in the development of its cannabinoid product line.

Forward-Looking Statements

This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Contact:
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and CEO
715-359-6373
rmitchell@PuramedBioScience.com
www.PuramedBioScience.com

SOURCE PuraMed BioScience, Inc.

Current LipiGesic M videos

  Dr. Cady videoDr. Roger Cady, discusses the results of treatment of migraine headache with fever few and ginger, the active ingredients in the migraine treatment LipiGesic® M.
VIEW NOW
  Sherry TorkosPharmacist Sherry Torkos recommends all-natural, homeopathic LipiGesic® M.
VIEW NOW
  Nutrition and J.J. Virgin fitness expert J.J. Virgin shares how LipiGesic® M has helped her teenage son eliminate migraine pain.
VIEW NOW

 

 

https://www.facebook.com/LipiGesicM
https://twitter.com/puramed
https://twitter.com/lipigesic

REBRANDING, TRADEMEARK AND PATENTS ARE NOW COMPLETE 07/30/2014
 

 

 

       

PMBS stuck @ .0001 again since February 2015!!
Will it ever break back above that again?? 



 

Blue Eagle Lithium
High Times
PMBS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMBS News: Amended Statement of Ownership (sc 13g/a) 07/27/2018 11:40:30 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#28651  Sticky Note I'll say it again, The proponents of this wodehouse 07/03/18 11:51:37 AM
#28855   "SHOULD SEE SOME UPDATES SOON!' And my name wodehouse 10/22/18 09:32:31 PM
#28854   Based on what? PMBS Neuronal 10/22/18 12:37:15 PM
#28853   SHOULD SEE SOME UPDATES SOON! buxcapital 10/22/18 11:49:43 AM
#28852   2s GOT HIT LOOKS NICE. buxcapital 10/16/18 09:53:15 PM
#28851   0 volume! Trading real good! Lol rs99 10/15/18 02:52:21 PM
#28850   Lol I may want some of that too! rs99 10/15/18 10:36:45 AM
#28849   "BACK TRADING LOOKING FOR UPDATES SOON!' I'll have wodehouse 10/15/18 10:30:28 AM
#28848   BID .0001 ask .0002 BACK TRADING LOOKING FOR buxcapital 10/13/18 11:46:22 AM
#28847   If a tree falls in the forest.... wodehouse 10/01/18 07:38:00 AM
#28846   Crickets ??! rs99 10/01/18 07:02:04 AM
#28845   Hey, at least there was some volume here. mikewazowski 09/20/18 05:33:38 PM
#28844   Yeah, a whopping $10 trade. Could have been wodehouse 09/20/18 03:22:11 PM
#28843   Nice buy good to see us back trading buxcapital 09/20/18 02:50:45 PM
#28842   Hey, do you think this is going to wodehouse 09/20/18 02:39:36 PM
#28841   The grays if they don’t file! rs99 09/13/18 12:31:13 PM
#28840   Tomorrow we open for trading again hope we buxcapital 09/12/18 02:08:55 PM
#28839   I think your right. skizimus 09/11/18 05:51:57 PM
#28838   I think we have all heard the last wodehouse 09/10/18 02:47:20 PM
#28837   Been a long time since it has been rs99 09/10/18 12:42:54 PM
#28836   (Crickets) rs99 09/08/18 03:02:12 PM
#28833   'I'm expecting a breakout at any time.' Did wodehouse 09/03/18 09:27:51 AM
#28832   That's all we can hope for now. mikewazowski 08/31/18 11:15:16 PM
#28831   Might be able trade once the ten days buxcapital 08/31/18 06:00:47 PM
#28830   Yeah, guess his charts were all for naught. wodehouse 08/31/18 12:39:45 PM
#28829   Lolol. To funny! Guess that chart lied! rs99 08/31/18 11:32:29 AM
#28828   I don't believe we'll hear from him again. wodehouse 08/31/18 09:52:23 AM
#28827   So how is that working out for you rs99 08/31/18 05:51:25 AM
#28826   Well said, rs99. I won't gloat either, over wodehouse 08/30/18 04:48:30 PM
#28825   Well, we have been called all kinds of rs99 08/30/18 03:20:13 PM
#28824   TenKay-thank you. wodehouse 08/30/18 09:24:24 AM
#28823   PMBS SEC SUSPENSION TenKay 08/29/18 09:27:49 PM
#28822   "telling everyone how bad a stock is for wodehouse 08/29/18 12:47:11 PM
#28821   I’m not 100% sure on how this works buxcapital 08/29/18 12:30:21 PM
#28820   Sounds like a good reason for him to skizimus 08/29/18 12:28:27 PM
#28819   Oh well. There goes a few bucks down mikewazowski 08/29/18 12:16:57 PM
#28818   My 300$ Will be ok but I was buxcapital 08/29/18 12:12:19 PM
#28817   I got out years ago, small loss. I wodehouse 08/29/18 12:07:58 PM
#28816   You been here so long only means buxcapital 08/29/18 12:03:12 PM
#28815   Didn't rs99 and I warn you all? wodehouse 08/29/18 11:50:27 AM
#28814   WOW CEO IS BEING ACCUSED OF USING THIS buxcapital 08/29/18 11:48:30 AM
#28813   Assuming it is an SEC suspension and the TenKay 08/29/18 11:35:46 AM
#28812   Can this resume trading ? buxcapital 08/29/18 11:30:35 AM
#28811   What is interesting is that there is no TenKay 08/29/18 11:09:50 AM
#28810   PMBS SEC Administrative Proceeding Initiated for Delinquency TenKay 08/29/18 11:04:55 AM
#28809   Sometimes the "scarecrow" is right. wodehouse 08/29/18 10:42:29 AM
#28808   Now theres a ass whoopin skizimus 08/29/18 10:18:42 AM
#28807   Thanks for the info. All those would-be millionaires wodehouse 08/29/18 10:14:31 AM
#28806   PMBS suspended; flaflyersfan 08/29/18 10:04:59 AM
#28805   That's funny but also very true..."The best corndefinitely Echo115 08/28/18 08:04:04 PM
#28804   I know. That's also kind of the reason mikewazowski 08/28/18 02:11:06 PM
PostSubject